WILLIAM A HAWKINS
CIK 1106508 · Chairman & CEO · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$45.42M
Companies
8
Total Filings
61
Lifetime Open-Market Net
$385.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MDXG | Director | 254,931 | $4.10 | $1.05M | $0 | 9 | 2026-06-12 |
| BIIB | Director | 10,365 | $206.60 | $2.14M | $0 | 8 | 2026-06-11 |
| BVS | Director | 297,640 | $13.30 | $3.96M | $235.6K | 13 | 2026-06-04 |
| AVNS | Director | 31,197 | $24.99 | $779.6K | $0 | 3 | 2021-01-06 |
| AVANOS MEDICAL, INC. (HYH) Delisted | Director | 17,651 | — | — | $0 | 5 | 2018-05-04 |
| THORATEC CORP (THOR) Delisted | Director | 0 | — | — | $0 | 5 | 2015-10-08 |
| MDT | Chairman & CEO | 434,032 | $85.71 | $37.20M | $149.8K | 15 | 2011-06-06 |
| DLX | Director | 11,333 | $26.40 | $299.2K | $0 | 3 | 2007-06-19 |
Recent Filings · Page 2 of 7
61 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-28 | BIIB | Grant (A) | +960 | $0 | EDGAR |
| 2023-06-15 | MDXG | Grant (A) | +35,354 | $175.0K | EDGAR |
| 2023-06-08 | BVS | Mixed | +16,648 | $0 | EDGAR |
| 2023-05-26 | BVS | Buy (P) | +88,000 | $235.6K | EDGAR |
| 2023-03-16 | BVS | Mixed | +3,949 | $0 | EDGAR |
| 2022-06-22 | BVS | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | BIIB | Grant (A) | +1,370 | $0 | EDGAR |
| 2022-06-13 | MDXG | Grant (A) | +44,191 | $175.0K | EDGAR |
| 2022-04-05 | BVS | Exer (M) | +40,573 | $0 | EDGAR |
| 2022-02-15 | BVS | Exer (M) | +13,500 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.